GL1X · GenesisL1 explorer

Research workbench

Crystal structure of L100I/K103N mutant HIV-1 reverse transcriptase (rt) in complex with TMC278 (rilpivirine), a non-nucleoside rt inhibitor

Analyse Crystal structure of L100I/K103N mutant HIV-1 reverse transcriptase (rt) in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2ZE2
Type
protein
Length
968 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Reverse TRANSCRIPTASE/RIBONUCLEASE H; P51 rt
EC
2.7.7.49, 2.7.7.7, 3.1.26.4
UniProt
P03366
Ligands
T27
Pockets
16 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AReverse TRANSCRIPTASE/RIBONUCLEASE H (EC 2.7.7.49, 2.7.7.7, 3.1.26.4)protein55228% helix, 20% strandP03366
BP51 rtprotein41633% helix, 18% strandP03366

Ligands and binding sites

  • T27 · 4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

16 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111430.810.82108T27
29350.800.8186empty
34090.730.8352empty
42800.630.8138empty
51190.550.8327empty

Interfaces

1 interface between chains.

  • A–B · 2625 Ų buried · 22 hydrogen bonds · protein-protein

Compared structures

  • 2ZE2 · Crystal structure of L100I/K103N mutant HIV-1 reverse transcriptase (RT) in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.